首页> 外文期刊>EFSA supporting publications >Report for 2011 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products
【24h】

Report for 2011 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products

机译:2011年关于活体动物和动物产品中兽药残留和其他物质监测结果的报告

获取原文
           

摘要

The report summarises the data collected from the monitoring on the presence of residues of veterinary medicinal products and certain substances in live animals and animal products in the European Union, in 2011. Altogether, 742,902 samples were reported to the European Commission. They included 415,909 targeted samples and 23,236 suspect samples reported under Council Directive 96/23/EC, 4,329 samples checked at import and 299,428 samples collected in the framework of programmes developed under the national legislation. The minimum requirements for sampling frequency laid down in Council Directive 96/23/EC and in Commission Decision 97/747/EC were fulfilled by the vast majority of Member States. The percentage of non- compliant targeted samples (0.28 %) was slightly lower compared to the previous four years (0.32 % – 0.34 %). The difference was triggered by the lower frequency of non-compliant samples for steroids, resorcyclic acid lactones, prohibited substances, antimicrobials, anthelmintics and anticoccidials. Conversely, the proportion of non-compliant samples for chemical elements (mainly metals) was similar to 2010 and higher compared to the period 2007 - 2009. This development is explained by the application since 2010 of a stricter legal basis in the evaluation of compliance for mercury and copper thus resulting in more non-compliant samples. For other substance groups, there were no notable variations in the overall frequency of non-compliant samples over the past five years.
机译:该报告汇总了2011年欧盟监测的兽药和某些物质在动物和动物产品中的兽药残留量的监测数据。总共向欧盟委员会报告了742,902个样品。其中包括根据理事会指令96/23 / EC报告的415909份目标样品和23236份可疑样品,进口时检查的4329份样品以及在国家立法制定的计划框架内收集的299428份样品。绝大多数成员国满足了理事会指令96/23 / EC和委员会决定97/747 / EC中规定的最低采样频率要求。与前四年(0.32%– 0.34%)相比,不合格的目标样品的百分比(0.28%)略低。差异的原因是类固醇,间环酸内酯,违禁物质,抗微生物剂,驱虫药和抗球虫药的不合规样品频率降低。相反,化学元素(主要是金属)不合格样品的比例与2010年相似,并且与2007年至2009年相比更高。这一发展是因为自2010年以来应用了更严格的法律依据来评估汞和铜,从而导致更多不合格样品。对于其他物质组,过去五年中不合格样品的总体频率没有明显变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号